Turkey: The impact of the alternative reimbursement legislation
Turkey's new alternative reimbursement legislation aims to modernize its healthcare sector by promoting innovative contracting.
It eases interactions with international pharmaceutical companies, ensures price confidentiality, and expedites product launches. However, Omar notes that companies are turning to these alternative methods due to challenges with Turkey's traditional reimbursement model, including high discounting rates. This shift is driving companies to develop more innovative contracting proposals for this alternative route.
An extract from September’s EU/UK/Asia session of Verpora's webinar series exploring the latest trends and policies surrounding Global Innovative Contracting, in EU, UK and Asia regions.
Register here for future events
Disclaimer: This presentation is for discussion purposes only, and is not intended as legal or policy advice. This presentation is based on non-confidential intelligence. Views expressed by the speakers are personal opinions and should not be attributed to anyone else. No part of this webinar may be reproduced for commercial purposes without the express permission of Verpora.
